MeiraGTx Holdings PLC (MGTX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$9.04

Buy

$9.08

arrow-up$0.395 (+4.56%)

Prices updated at 01 Apr 2026, 16:49 EDT

Prices minimum 15 mins delay

Prices in USD

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.

NASDAQ

1.56%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$9.26 - $8.75
	$9.73 - $4.55
	-
	561.02m
	-
	-
	621,032
	-
	504,260.01
	0.75
	81.12m
	KYG596651029
	-1.42
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.